Oculis Holding AG (OCS) EPS (Basic) (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly EPS (Basic) of -$0.05 in Q1 2026, down 147.61% quarter-over-quarter from $0.11 in Q4 2025, and up 29.88% on a YoY basis from -$0.04 in Q1 2025.
Oculis Holding AG (OCS) EPS (Basic) (2022 - 2026) Analysis & Trends
Oculis Holding AG's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.05 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 29.88% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$36.05 (up 39.29% YoY), while the FY2025 annual figure was -$0.18, up 27.87% from the prior year.
- EPS (Basic) was -$0.05 for Q1 2026 at Oculis Holding AG, down from $0.11 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.11 in Q4 2025 to a low of -$59.16 in Q3 2024.
- Historically, EPS (Basic) has averaged -$8.19 across 5 years, with a median of -$0.07 in 2023.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) slumped 96477.35% in 2024, then jumped 224.73% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$2.36 in 2022, then soared by 85.55% to -$0.34 in 2023, then jumped by 75.29% to -$0.08 in 2024, then soared by 224.73% to $0.11 in 2025, then slumped by 147.61% to -$0.05 in 2026.
- The last three EPS (Basic) figures came in at -$0.05 (Q1 2026), $0.11 (Q4 2025), and -$36.05 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.06 |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | -36.05 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -59.16 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.04 |
| Dec 31, 2022 | -2.36 |